These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 24465551)

  • 1. Cysteine peptidases as schistosomiasis vaccines with inbuilt adjuvanticity.
    El Ridi R; Tallima H; Selim S; Donnelly S; Cotton S; Gonzales Santana B; Dalton JP
    PLoS One; 2014; 9(1):e85401. PubMed ID: 24465551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective immune responses against Schistosoma mansoni infection by immunization with functionally active gut-derived cysteine peptidases alone and in combination with glyceraldehyde 3-phosphate dehydrogenase.
    Tallima H; Dvořák J; Kareem S; Abou El Dahab M; Abdel Aziz N; Dalton JP; El Ridi R
    PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005443. PubMed ID: 28346516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of protective immune responses against schistosomiasis using functionally active cysteine peptidases.
    El Ridi R; Tallima H; Dalton JP; Donnelly S
    Front Genet; 2014; 5():119. PubMed ID: 24847355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immune potential of multiple antigenic peptide (MAP) constructs comprising peptides that are shared by several cysteine peptidases against Schistosoma mansoni infection in mice.
    Al-Naseri A; Al-Absi S; Mahana N; Tallima H; El Ridi R
    Mol Biochem Parasitol; 2022 Mar; 248():111459. PubMed ID: 35041897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential protective impact of peptide vaccine formulae targeting the lung- and liver-stage of challenge Schistosoma mansoni infection in mice.
    Tallima H; Tadros MM; El Ridi R
    Acta Trop; 2024 Jun; 254():107208. PubMed ID: 38621620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant.
    Ricciardi A; Dalton JP; Ndao M
    Vaccine; 2015 Jan; 33(2):346-53. PubMed ID: 25448114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papain-Based Vaccination Modulates Schistosoma mansoni Infection-Induced Cytokine Signals.
    Abdel Aziz N; Tallima H; Hafez EA; El Ridi R
    Scand J Immunol; 2016 Feb; 83(2):128-38. PubMed ID: 26603950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine-induced protection against murine schistosomiasis mansoni with larval excretory-secretory antigens and papain or type-2 cytokines.
    El Ridi R; Tallima H
    J Parasitol; 2013 Apr; 99(2):194-202. PubMed ID: 22985345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of Protective Immune Responses Against Schistosomiasis haematobium in Hamsters and Mice Using Cysteine Peptidase-Based Vaccine.
    Tallima H; Dalton JP; El Ridi R
    Front Immunol; 2015; 6():130. PubMed ID: 25852696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvanted
    Perera DJ; Hassan AS; Jia Y; Ricciardi A; McCluskie MJ; Weeratna RD; Ndao M
    Front Immunol; 2020; 11():605288. PubMed ID: 33304354
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Morais SB; Figueiredo BC; Assis NRG; Homan J; Mambelli FS; Bicalho RM; Souza C; Martins VP; Pinheiro CS; Oliveira SC
    Front Immunol; 2018; 9():1762. PubMed ID: 30105029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and vaccine potential of dipeptidic multiple antigen peptides from Schistosoma mansoni glyceraldehyde 3-phosphate dehydrogenase.
    El Ridi R; Montash M; Tallima H
    Scand J Immunol; 2004 Oct; 60(4):392-402. PubMed ID: 15379864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A low dose adenovirus vectored vaccine expressing Schistosoma mansoni Cathepsin B protects from intestinal schistosomiasis in mice.
    Perera DJ; Hassan AS; Liu SS; Elahi SM; Gadoury C; Weeratna RD; Gilbert R; Ndao M
    EBioMedicine; 2022 Jun; 80():104036. PubMed ID: 35500538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against Schistosoma haematobium infection in hamsters by immunization with Schistosoma mansoni gut-derived cysteine peptidases, SmCB1 and SmCL3.
    Tallima H; Abou El Dahab M; Kareem S; Dalton JP; El Ridi R
    Vaccine; 2017 Dec; 35(50):6977-6983. PubMed ID: 29122387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of Schistosoma mansoni cathepsins B and L by human IgG1 and IgG4 antibodies.
    Grogan J; Rotmans P; Ghoneim H; Deelder A; Yazdanbakhsh M; Klinkert MQ
    Parasite Immunol; 1997 May; 19(5):215-20. PubMed ID: 9194098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A vaccine consisting of Schistosoma mansoni cathepsin B formulated in Montanide ISA 720 VG induces high level protection against murine schistosomiasis.
    Ricciardi A; Visitsunthorn K; Dalton JP; Ndao M
    BMC Infect Dis; 2016 Mar; 16():112. PubMed ID: 26945988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal delivery of a formulation containing stage-specific recombinant proteins of Fasciola hepatica cathepsin L5 and cathepsin B2 triggers an anti-fecundity effect and an adjuvant-mediated reduction in fluke burden in sheep.
    Norbury LJ; Basałaj K; Zawistowska-Deniziak A; Sielicka A; Wilkowski P; Wesołowska A; Smooker PM; Wędrychowicz H
    Vet Parasitol; 2018 Jul; 258():14-23. PubMed ID: 30105973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems.
    Vicente B; López-Abán J; Rojas-Caraballo J; del Olmo E; Fernández-Soto P; Muro A
    Parasit Vectors; 2016 Apr; 9():216. PubMed ID: 27090442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased hepatic interleukin-1, arachidonic acid, and reactive oxygen species mediate the protective potential of peptides shared by gut cysteine peptidases against Schistosoma mansoni infection in mice.
    Tallima H; El Ridi R
    PLoS Negl Trop Dis; 2023 Mar; 17(3):e0011164. PubMed ID: 36920999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination against the digestive enzyme Cathepsin B using a YS1646 Salmonella enterica Typhimurium vector provides almost complete protection against Schistosoma mansoni challenge in a mouse model.
    Hassan AS; Zelt NH; Perera DJ; Ndao M; Ward BJ
    PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007490. PubMed ID: 31790394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.